|
|||||||||
|
|||||||||
| 解禁日 | 解禁股数(万股) | 占总股比例 | 解禁股类型 |
|---|---|---|---|
| 2024-07-27 | 31.96 | 0.06% | 股权激励 |
| 2024-01-08 | 123.42 | 0.22% | 股权激励 |
| 2023-07-27 | 31.02 | 0.05% | 股权激励 |
| 2023-01-09 | 119.79 | 0.21% | 股权激励 |
| 总股本(亿股) | 7.73 | 100% |
| 流通A股(亿股) | 5.66 | 73% |
| 限售流通股(亿股) | 0.08 | 1% |
| B股(亿股) | 0.00 | 0% |
| H股(亿股) | 0.00 | 0% |
| 十大流通股东 | 持有比例 | 本期持有股(万股) | 持股变动数(万股) |
|---|---|---|---|
| 天津市医药集团有限公司 | 42.81% | 33,112.05 | 新进 |
| ABN AMRO CLEARING BANK | 3.95% | 3,054.60 | 新进 |
| PHILLIP SECURITIES PTE | 3.36% | 2,602.01 | 新进 |
| DBS NOMINEES PTE LTD | 2.63% | 2,034.09 | 新进 |
| RAFFLES NOMINEES(PTE)L | 2.49% | 1,928.86 | 新进 |
| CITIBANK NOMS SPORE PT | 2.01% | 1,552.73 | 新进 |
| 冯志浩 | 1.94% | 1,500.00 | 新进 |
| 香港中央结算有限公司 | 1.66% | 1,281.47 | 减持663.12 |
| MORGAN STANLEY ASIA(S) | 0.67% | 516.92 | 新进 |
| LU ZU LIANG | 0.60% | 461.00 | 新进 |
| 十大股东 | 持有比例 | 本期持有股(万股) | 持股变动数(万股) |
|---|---|---|---|
| 天津市医药集团有限公司 | 42.81% | 33,112.05 | 不变 |
| ABN AMRO CLEARING BANK | 3.95% | 3,054.60 | 减持194.76 |
| PHILLIP SECURITIES PTE | 3.36% | 2,602.01 | 增持128.99 |
| DBS NOMINEES PTE LTD | 2.63% | 2,034.09 | 减持158.06 |
| RAFFLES NOMINEES(PTE)L | 2.49% | 1,928.86 | 减持6.09 |
| CITIBANK NOMS SPORE PT | 2.01% | 1,552.73 | 减持10.40 |
| 冯志浩 | 1.94% | 1,500.00 | 新进 |
| 香港中央结算有限公司 | 1.66% | 1,281.47 | 减持663.12 |
| MORGAN STANLEY ASIA(S) | 0.67% | 516.92 | 减持4.43 |
| LU ZU LIANG | 0.60% | 461.00 | 增持55.29 |
| 时间 | 股东人数 | 比上期 | 人均持股 | 比上期 |
|---|---|---|---|---|
| 2022-03-31 | 32235 | +8.80% | 2.40万股 | -8.09% |
| 2021-12-31 | 29629 | -2.54% | 2.61万股 | +2.58% |
| 2021-09-30 | 30401 | +4.67% | 2.54万股 | -4.46% |
| 2021-06-30 | 29045 | +2.79% | 2.66万股 | -2.71% |
| 2021-03-31 | 28256 | -11.10% | 2.74万股 | +12.49% |
| 2020-12-31 | 31784 | -9.68% | 2.43万股 | +10.71% |
| 2020-09-30 | 35192 | -2.69% | 2.20万股 | +2.89% |
| 2020-06-30 | 36165 | +7.51% | 2.14万股 | -6.99% |
|
